Changes in electrical properties of command neurons during protective effect of low doses of antibodies to S100 protein on the development of long-term sensitization in helix lucorum

Bulletin of Experimental Biology and Medicine

Volumn 148, Issue 4, 2009, Pages 598-601

  Timoshenko, A Kh ^a   Andrianov, V V ^a   Gainutdinova, T Kh ^a   Gainutdinov, Kh L ^a   Muranova, L N ^a   Tagirova, R R ^a   Shtark, M B ^b   Epstein, O I ^c  

^a ZAVOISKY PHYSICAL TECHNICAL INSTITUTE   (Russian Federation)

^b INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^c Materia Medica Holding R   (Russian Federation)

Author keywords

Antibodies to S100; Ca2+ binding protein S100; Long term sensitization; Membrane and threshold potential; Neurobiological model of anxiety and depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CALCIUM ION; PROTEIN ANTIBODY; PROTEIN S 100; PROTEIN S 100 ANTIBODY; UNCLASSIFIED DRUG;

ANXIETY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; DEPRESSION; DRUG MECHANISM; LONG TERM POTENTIATION; NERVE CELL MEMBRANE POTENTIAL; NONHUMAN; REGULATORY MECHANISM; SENSITIZATION; SNAIL;

ANIMALS; ANTIBODIES; BEHAVIOR, ANIMAL; ELECTROPHYSIOLOGY; HELIX (SNAILS); MEMBRANE POTENTIALS; NEURONS; S100 PROTEINS;

HELIX LUCORUM;

EID: 77952093329     PISSN: 00074888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10517-010-0773-y     Document Type: Article

References (15)

1. P. M. Balaban, I. S. Zakharov, Learning and Development. Bases of Two Phenomena [Russian], Moscow (1992).
2. T Kh Gainuitdinova VV Andrianov RR Nazyrova Kh L Gainutdinov 1999 Zh. Vyssh. Nerv. Deiat. 49 6 1063 1065
3. Kh L Gainutdinov VV Andrianov NA Beregovoy, et al. 2006 Zhurn. Evol. Biochim. Physiol. 42 3 225 230
4. LV Loskutova MB Shtark OI Epshtein 2003 Byull. Eksp. Biol. Med. 136 1 24 26 10.1023/A:1024797722719 (Pubitemid 38095905)
5. TM Pankova MV Starostina MB Shtark, et al. 2007 Byull. Eksp. Biol. Med. 144 9 260 263
6. IA Kheyfets Yu L Dugina TA Voronina, et al. 2007 Byull. Eksp. Biol. Med. 143 5 535 537
7. OI Epstein OV Vorobieva LN Grinkevich, et al. 2007 Byull. Eksp. Biol. Med. 144 9 293 296
8. OI Epstein MB Shtark A Kh Timoshenko, et al. 2007 Byull. Eksp. Biol. Med. 143 5 490 493 10.1007/s10517-007-0179-7 (Pubitemid 47517116)
9. EG Antzoulatos ML Wainwright LJ Cleary JH Byrne 2006 Learn. Mem 13 4 422 425 10.1101/lm.230306 16847306 (Pubitemid 44157466)
10. V Castagne M Lemaire I Kheyfets, et al. 2008 J. Pharm. Pharmacol. 60 3 309 316 10.1211/jpp.60.3.0005 1:CAS:528:DC%2BD1cXisFKmtbk%3D 18284810 (Pubitemid 351269817)
11. LJ Cleary WL Lee JH Byrne 1998 J. Neurosci. 18 15 5988 5998 1:CAS:528:DyaK1cXkvFWntbs%3D 9671684
12. OI Epstein NA Beregovoy MV Starostina, et al. 2003 Front. Biosci. 8 a79 a84 10.2741/1025 1:CAS:528:DC%2BD3sXjvVWlsr4%3D 12700037
13. RD Hawkins ER Kandel CH Bailey 2006 Biol. Bull. 210 3 174 191 10.2307/4134556 1:CAS:528:DC%2BD28XnsVahu7c%3D 16801493
14. H Kubista R Donato A Hermann 1998 Neuroscience 90 2 493 508 10.1016/S0306-4522(98)00422-9
15. FX Soriano S Papadia F Hofmann, et al. 2006 J. Neurosci. 26 17 4509 4518 10.1523/JNEUROSCI.0455-06.2006 1:CAS:528:DC%2BD28XksFWqtb8%3D 16641230 (Pubitemid 44315350)